Public perception of disease is everything. “Diabetics” are now referred to as “people living with diabetes”; an “obese person” is now an “individual living with
Undermyfork diabetes management app co-founders Mike Ushakov, Eugene Molodkin, and Nikita Shulaev are combining meal tracking and continuous glucose monitoring (CGM) data in a clinically-validated
A groundbreaking personalised health system has been launched that aims to put the over 50s in control of wellbeing as they age. The GHS, developed
The FDA is warning people to avoid using compounded medicines as substitutes for the popular weight loss and diabetes drugs Ozempic, Rybelsus, and Wegovy. Compounded
Micron Biomedical, who develop dissolvable, microarray-based products to simplify the delivery of drugs and vaccines, have announced that they have added $3m to its Series
Allurion, maker of a swallowable gastric balloon designed to facilitate weight loss, has partnered with Medtronic in a pilot agreement to distribute the device in
Metformin, a drug commonly used to treat diabetes, can reduce the risk of developing long COVID by over 40%, according to a study published in
A novel treatment for healing diabetic foot ulcers (DFUs) could be on the horizon for people with diabetes in the US. Diabetic foot ulcers are
Nemaura Medical has announced interim results from its collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program. Known as
From April 2023 Medicare has increased access to continuous glucose monitoring (CGM) in the US to people on insulin therapies who are also having hypoglycemia.
